NDC 17856-0048-01 - POTASSIUM CHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0048
- Requested NDC
- 17856-0048-01
- Package NDCs from labels
- 17856-0048-2, 17856-0048-1, 17856-0048-4, 17856-0048-3, 17856-0048-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-12-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POTASSIUM CHLORIDE - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2025-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0048-1 | POTASSIUM CHLORIDE | 72 in 1 BOX, UNIT-DOSE | SOLUTION | 72 | 3 | |
| 17856-0048-2 | POTASSIUM CHLORIDE | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 3 | |
| 17856-0048-3 | POTASSIUM CHLORIDE | 50 in 1 BOX, UNIT-DOSE | SOLUTION | 50 | 3 | |
| 17856-0048-4 | POTASSIUM CHLORIDE | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0048 | POTASSIUM CHLORIDE (POTASSIUM CHLORIDE ORAL) SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, 4 package rows | 20240712_dc55474c-cc51-4f17-8cb3-0f34b3e68a55.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0048-1 | ML - Milliliter | 17856-0048 | fa753217-b4f9-4eea-aa65-cd8f04a1b755 | 1 | 2025-06-13 |
| 17856-0048-3 | ML - Milliliter | 17856-0048 | 254d2f5e-601d-417e-9b81-b482f52a56a1 | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 7427c29e-55c1-4c30-b091-058c8bec592f | 2024-08-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | f1791d4f-029a-487f-aee1-fc5be246d0bc | 2024-08-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Up and Up Hemorrhoid MAX STRENGTH | 14.4% GLYCERIN, 0.25% PHENYLEPHRINE HCL, 1% PRAMOXINE HCL, 15% PETROLATUM | Target Corporation | 867677b5-fd1d-449e-966e-1de0b5c98afb | 2024-08-08 | Warnings | PDC6A3C0OX |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 80dd5de2-5066-472b-b1f8-88070a5c7388 | 2024-08-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Drainage | ECHINACEA (ANGUSTIFOLIA), TRIFOLIUM PRATENSE, PHYTOLACCA DECANDRA, CALCAREA IODATA, KALI MURIATICUM, NITRICUM ACIDUM, PHOSPHORICUM ACIDUM, SULPHUR IODATUM | BioActive Nutritional, Inc. | 7920e8f6-be48-4402-9085-9673779db5a2 | 2024-07-31 | Warnings | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | 3849b89c-c309-46fb-a1e2-53ff0c65077f | 2024-07-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Bryant Ranch Prepack | 7b8e7a4f-0d44-46b2-9565-7b4c294e9fcb | 2024-07-18 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Bryant Ranch Prepack | b5a6b6f2-d073-4bd3-a66c-bf34ccabfe51 | 2024-07-18 | Warnings, Adverse reactions | 660YQ98I10 |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | American Health Packaging | 58fa9952-c8ab-4ebb-a073-15cc45f4832a | 2024-07-16 | Adverse reactions | XF417D3PSL |
| Thompson Safety Eyewash | WATER | Thompson Safety | 1d0e96cf-245b-cfb7-e063-6294a90a4ced | 2024-07-12 | Warnings | 059QF0KO0R |
| WINTER BLEND | ECHINACEA (ANGUSTIFOLIA), UVA-URSI, BAPTISIA TINCTORIA, CONVALLARIA MAJALIS, KALI MURIATICUM, PINUS SYLVESTRIS, THUJA OCCIDENTALIS, BRYONIA, CROTALUS HORRIDUS, LACHESIS MUTUS, SELENIUM METALLICUM, VISCUM ALBUM | Energique, Inc. | ff696389-bad5-463a-be99-e92e86250e86 | 2024-07-12 | Warnings | 660YQ98I10 |
| Zenibell Snail IntensiveCream | GLYCERIN | MISOCOS | 97c19dca-237c-c968-e053-2a95a90aeae7 | 2024-07-05 | Warnings | PDC6A3C0OX |
| Zenibell Snail Intensive Toner | GLYCERIN | MISOCOS | 97c1b556-824d-bef7-e053-2a95a90ae1f2 | 2024-07-05 | Warnings | PDC6A3C0OX |
| aewajin Derma Hydrocell | GLYCERIN | MISOCOS | 980fcaea-27ba-da49-e053-2995a90ad506 | 2024-07-05 | Warnings | PDC6A3C0OX |
| aewajin Derma Hydrocell 24k Gold Serum | GLYCERIN | MISOCOS | a17b2c6e-9db8-bae4-e053-2a95a90adcf6 | 2024-07-05 | Warnings | PDC6A3C0OX |
| Bunnies Bum Soothing Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | FloCal Distributors LLC | 1c81582c-7ece-182f-e063-6294a90a8fbc | 2024-07-05 | Warnings | PDC6A3C0OX |
| Zenibell Snail Intensive | GLYCERIN | MISOCOS | 97747267-26f1-d06f-e053-2a95a90ab087 | 2024-07-04 | Warnings | PDC6A3C0OX |
| Isolyte P in Dextrose | DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC | B. Braun Medical Inc. | 4ea4397c-2fa4-4670-91e6-21ae498c88f7 | 2024-06-24 | Warnings, Adverse reactions | 660YQ98I10 |
| ABREVA Rapid Pain Relief | GLYCERIN, LIDOCAINE | Haleon US Holdings LLC | 65bd242f-4c6a-436c-8ec0-7b2e0d73ed9d | 2024-06-20 | Warnings | PDC6A3C0OX |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | ad42a7e3-84ea-390d-e053-2a95a90a3a32 | 2024-06-14 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.